2327143
Last Update Posted: 2018-08-06
Recruiting has ended
All Genders accepted | 18 Years-65 Years |
11 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
A Study of LY2835219 in Healthy Participants
The aim of this study is to compare how much of the study drug gets into the blood stream when it is given as a single oral dose and as an intravenous infusion (given directly into a vein via a small needle).
The study will also provide information on how well the study drug is tolerated when given as a capsule in combination with giving it intravenously, and information on any changes in heart function.
The study will last about 10 days. Screening is required within 28 days before study drug is given.
Eligibility
Relevant conditions:
Healthy Volunteers
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov